Hepatitis B surface antigen clearance and appearance of antibodies against hepatitis B surface antigen after treatment with recombinant interleukin 2 in a human immunodeficiency virus-infected patient.
Gianotti
N
N
Uberti-Foppa
C
C
Boeri
E
E
Marinelli
M
M
Tambussi
G
G
Finazzi
R
R
Lazzarin
A
A
D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis* / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens; D007376:Interleukin-2; D011994:Recombinant Proteins